314 related articles for article (PubMed ID: 19101526)
1. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
Furuichi Y; Maeda M; Matsuoka N; Mutoh S; Yanagihara T
Exp Neurol; 2007 Mar; 204(1):138-46. PubMed ID: 17169359
[TBL] [Abstract][Full Text] [Related]
3. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
4. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
[TBL] [Abstract][Full Text] [Related]
5. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
Copin JC; Gasche Y
Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
[TBL] [Abstract][Full Text] [Related]
6. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Romanos E; Planas AM; Amaro S; Chamorro A
J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
[TBL] [Abstract][Full Text] [Related]
7. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
8. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T
J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance angiography of thromboembolic stroke in rats: indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment.
Hilger T; Niessen F; Diedenhofen M; Hossmann KA; Hoehn M
J Cereb Blood Flow Metab; 2002 Jun; 22(6):652-62. PubMed ID: 12045663
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat.
Noto T; Ishiye M; Furuich Y; Keida Y; Katsuta K; Moriguchi A; Matsuoka N; Aramori I; Goto T; Yanagihara T
Brain Res Mol Brain Res; 2004 Sep; 128(1):30-8. PubMed ID: 15337315
[TBL] [Abstract][Full Text] [Related]
12. Effects of alteplase, a thrombolytic agent, in a rat photothrombotic middle cerebral artery occlusion model.
Umemura K; Higo K; Sakata T; Yuki S; Iwata K; Yamaguchi K
Pathophysiol Haemost Thromb; 2008; 36(5):245-50. PubMed ID: 19996634
[TBL] [Abstract][Full Text] [Related]
13. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
Yi JS; Kim YH; Koh JY
Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485
[TBL] [Abstract][Full Text] [Related]
14. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
15. rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia.
Burggraf D; Martens HK; Dichgans M; Hamann GF
Brain Res; 2007 Aug; 1164():55-62. PubMed ID: 17644075
[TBL] [Abstract][Full Text] [Related]
16. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
Lu HT; Zhao JG; Li MH; Li YD
Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
[TBL] [Abstract][Full Text] [Related]
17. Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs.
Absher PM; Hendley E; Jaworski DM; Taatjes DJ; Sobel BE
Coron Artery Dis; 1999 Sep; 10(6):413-20. PubMed ID: 10474793
[TBL] [Abstract][Full Text] [Related]
18. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG
Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]